Christopher G. Rowe

507 total citations
13 papers, 394 citations indexed

About

Christopher G. Rowe is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Christopher G. Rowe has authored 13 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Public Health, Environmental and Occupational Health and 6 papers in Immunology. Recurrent topics in Christopher G. Rowe's work include Malaria Research and Control (6 papers), vaccines and immunoinformatics approaches (4 papers) and Mosquito-borne diseases and control (3 papers). Christopher G. Rowe is often cited by papers focused on Malaria Research and Control (6 papers), vaccines and immunoinformatics approaches (4 papers) and Mosquito-borne diseases and control (3 papers). Christopher G. Rowe collaborates with scholars based in United States and Denmark. Christopher G. Rowe's co-authors include David L. Narum, Patrick E. Duffy, Kelly M. Rausch, D. Stephen Charnock‐Jones, F. C. Thomas Allnutt, Robert M. Bowers, Arun K. Dhar, Puthupparampil V. Scaria, Lynn Lambert and Yimin Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Infection and Immunity.

In The Last Decade

Christopher G. Rowe

13 papers receiving 386 citations

Peers

Christopher G. Rowe
Jenifer B. Kaplan United States
Daniel M. N. Okenu United States
Sung-Ung Moon South Korea
Eileen D. Franke United States
Amy R. Noe United States
Jenifer B. Kaplan United States
Christopher G. Rowe
Citations per year, relative to Christopher G. Rowe Christopher G. Rowe (= 1×) peers Jenifer B. Kaplan

Countries citing papers authored by Christopher G. Rowe

Since Specialization
Citations

This map shows the geographic impact of Christopher G. Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. Rowe more than expected).

Fields of papers citing papers by Christopher G. Rowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher G. Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. Rowe. The network helps show where Christopher G. Rowe may publish in the future.

Co-authorship network of co-authors of Christopher G. Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. Rowe. A scholar is included among the top collaborators of Christopher G. Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. Rowe. Christopher G. Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Scaria, Puthupparampil V., Nicole Roth, Olga Muratova, et al.. (2024). mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response. npj Vaccines. 9(1). 9–9. 17 indexed citations
2.
Scaria, Puthupparampil V., Christopher G. Rowe, Thayne H. Dickey, et al.. (2022). Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines. iScience. 25(8). 104739–104739. 4 indexed citations
3.
Scaria, Puthupparampil V., Charles Anderson, Olga Muratova, et al.. (2021). Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques. npj Vaccines. 6(1). 148–148. 12 indexed citations
4.
Scaria, Puthupparampil V., Christopher G. Rowe, Olga Muratova, et al.. (2020). Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230. Vaccine. 38(34). 5480–5489. 17 indexed citations
5.
Scaria, Puthupparampil V., Christopher G. Rowe, Olga Muratova, et al.. (2019). Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230. npj Vaccines. 4(1). 24–24. 42 indexed citations
6.
Scaria, Puthupparampil V., Christopher G. Rowe, D. Stephen Charnock‐Jones, et al.. (2017). Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity. PLoS ONE. 12(12). e0190312–e0190312. 31 indexed citations
7.
Charnock‐Jones, D. Stephen, Christopher G. Rowe, Karine Reiter, et al.. (2016). A Method for Producing Protein Nanoparticles with Applications in Vaccines. PLoS ONE. 11(3). e0138761–e0138761. 20 indexed citations
8.
Shimp, Richard L., Christopher G. Rowe, Karine Reiter, et al.. (2013). Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle. Vaccine. 31(28). 2954–2962. 79 indexed citations
9.
Zhu, Daming, Feng Qian, Yimin Wu, et al.. (2012). Determination of protein concentration for protein–protein conjugates using ultraviolet absorption. Journal of Immunological Methods. 387(1-2). 317–321. 9 indexed citations
10.
Dhar, Arun K., Robert M. Bowers, Christopher G. Rowe, & F. C. Thomas Allnutt. (2010). Expression of a foreign epitope on infectious pancreatic necrosis virus VP2 capsid protein subviral particle (SVP) and immunogenicity in rainbow trout. Antiviral Research. 85(3). 525–531. 24 indexed citations
11.
Avril, Marion, Bridget R. Kulasekara, Christopher G. Rowe, et al.. (2008). Evidence for Globally Shared, Cross-Reacting Polymorphic Epitopes in the Pregnancy-Associated Malaria Vaccine Candidate VAR2CSA. Infection and Immunity. 76(4). 1791–1800. 43 indexed citations
12.
Allnutt, F. C. Thomas, Robert M. Bowers, Christopher G. Rowe, et al.. (2007). Antigenicity of infectious pancreatic necrosis virus VP2 subviral particles expressed in yeast. Vaccine. 25(26). 4880–4888. 35 indexed citations
13.
Knight, Matty, André Miller, Christopher G. Rowe, et al.. (1999). The identification of markers segregating with resistance to Schistosoma mansoni infection in the snail Biomphalaria glabrata. Proceedings of the National Academy of Sciences. 96(4). 1510–1515. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026